Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  Akt inhibitor AZD5363
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: D3610C00001, NCI-2014-01803, EudraCT number: 2010-022167-35, NCT01226316
Start Over